Nationwide Opioid Settlement May Provide Path For Other Manufacturers
Executive Summary
J&J and distributors have enough participation from states and subdivisions to move forward with $26bn settlement. The deal, the second largest in US history, may provide a framework for other companies to reach similar agreements. Jury trials remain pending in several states.
You may also be interested in...
Walgreens And CVS Agree To Opioid Settlements, But States Waiting To See Details
As states weigh their options, the history of past settlements will be a factor. One state signed onto the settlement with the distributors but opted out of the deal with J&J, netting it millions more, and with faster payment, than it would have received under the national settlement.
Teva Wins Support For Nationwide Opioid Settlement With Bigger Cash Offer
Teva to pay $4.25bn over 13 years under agreement in principle with 12 state attorneys general, Native American tribes and plaintiffs’ lawyers. Previous settlement offer provided mostly medication. Deal is contingent on governments signing on and Allergan inking settlement.
Teva Settles With San Francisco But New York Could Be Set To Prize Open Old Wounds
Teva has settled the final outstanding advanced US state-level opioid-related case against the firm, but recent allegations from the New York attorney general could see the firm back in court sooner rather than later.